Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter, Controlled Study Comparing the Outcomes of Primary Total Hip Arthroplasty Devices Manufactured in China Versus Devices Manufactured Outside of China

NCT02399007 is registered in ClinicalTrials.gov with Johnson & Johnson Medical (Suzhou) Ltd. as lead sponsor.

NCT NCT02399007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02399007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter, Controlled Study Comparing the Outcomes of Primary Total Hip Arthroplasty Devices Manufactured in China Versus Devices Manufactured Outside of China
Lead sponsor
Johnson & Johnson Medical (Suzhou) Ltd.
Phase
Not applicable
Overall status
Completed
Start date
June 7, 2015
Completion date
January 17, 2018
Enrollment
160 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, congenital hip dysplasia, rheumatoid arthritis